Reyon Pharm will make its debut on the bourse on June 10 after its initial public offering (IPO) of 1.3 million shares.
The drug maker said the IPO price is set at 165,000 won.
Reyon succeeded in synthesizing arbekasin sulfate and aminoglycoside antibiotics for the second time in the world in 1989.
Especially, the company has performed the clinical trial for VM202RY, a gene agent in co...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.